Vaqta Pediatric/Adolescent

Vaqta Pediatric/Adolescent is an inactivated hepatitis A vaccine designed for children and adolescents aged 12 months to 18 years. It helps protect against hepatitis A virus infection by stimulating the immune system. This vaccine is administered via injection and is suitable for routine immunization schedules.

Vaqta Pediatric/Adolescent is used to prevent hepatitis A virus infection in children and adolescents. It is recommended for routine vaccination starting at 12 months of age. The vaccine helps the immune system recognize and fight the hepatitis A virus, reducing the risk of infection. Parents and caregivers often ask, 'what is Vaqta Pediatric/Adolescent used for?' to understand its role in protecting young individuals from this contagious liver disease.

After vaccination, the body produces antibodies to the hepatitis A virus, providing immunity. Most children and adolescents tolerate the vaccine well, with common effects including mild soreness at the injection site or low-grade fever. These effects are typically temporary and resolve within a few days. The vaccine does not cause hepatitis A infection, as it contains an inactivated form of the virus.

Vaqta Pediatric/Adolescent should be stored refrigerated between 2°C and 8°C (36°F and 46°F) and protected from light. It is important to inform the healthcare provider of any allergies, especially to neomycin or previous vaccine components. Children with severe illnesses or fever should delay vaccination until recovered. Always discuss medical history with a healthcare professional before vaccination.

Vaqta Pediatric/Adolescent can be administered simultaneously with other childhood vaccines, such as MMR or DTaP, without affecting efficacy. However, it is important to inform the healthcare provider about any other medications or immune system conditions. Live vaccines should not be given within 4 weeks of Vaqta to avoid potential interference with immune response. Blood products or immune globulins may reduce vaccine effectiveness if given close to the vaccination date.